These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38401715)

  • 1. Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism.
    Wang J; Hu Y; Li Q; Liu YN; Lin J; Xu RA
    Chem Biol Interact; 2024 Apr; 392():110924. PubMed ID: 38401715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism.
    Liu YN; Chen J; Wang J; Li Q; Hu GX; Cai JP; Lin G; Xu RA
    Arch Toxicol; 2023 Aug; 97(8):2133-2142. PubMed ID: 37209178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism.
    Ye Z; Hu J; Wang J; Liu YN; Hu GX; Xu RA
    Chem Biol Interact; 2023 Apr; 374():110398. PubMed ID: 36773832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the antitumor drugs adagrasib and asciminib on apixaban metabolism in vitro and in vivo.
    Shen Y; Chen X; Wu H; Xia H; Xu RA
    Chem Biol Interact; 2024 Aug; 399():111146. PubMed ID: 39002878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism.
    Zhou Q; Ye F; Ye Z; Gao N; Kong Q; Hu X; Qian J; Wu B
    PeerJ; 2023; 11():e16601. PubMed ID: 38089912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of UPLC-MS/MS method for studying the pharmacokinetic interactions of fuzuloparib with curcumin in rats.
    Wu H; Xie S; Chen X; Xia H; Shen Y; Xu RA; Tan W; Zhan R
    J Pharm Biomed Anal; 2024 Oct; 249():116383. PubMed ID: 39096626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Dietary Flavonoids on the Metabolism of Vortioxetine and its Potential Mechanism.
    Lin Y; Wang Y; Ye Z; Gao N; Xu X; Weng Q; Xu RA; Ye L
    Curr Med Chem; 2024; 31(23):3624-3630. PubMed ID: 37287287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone.
    Li Q; Wang J; Wang ZL; Shen Y; Zhou Q; Liu YN; Hu GX; Cai JP; Xu RA
    Biomed Pharmacother; 2023 Dec; 168():115833. PubMed ID: 37935069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism.
    Ye Z; Xia H; Hu J; Liu YN; Wang A; Cai JP; Hu GX; Xu RA
    Biomed Pharmacother; 2024 Jun; 175():116421. PubMed ID: 38719708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
    Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of imperatorin on dabrafenib metabolism in vitro and in vivo.
    Xia H; Wu H; Chen J; Xu X; Tan W; Xu RA
    Chem Biol Interact; 2024 Aug; 399():111131. PubMed ID: 38964639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of flavonoids and CYP3A4 variants on midostaurin metabolism.
    Xu RA; Li QQ; Gao NY; Wang J; Li XY; Ye F; Ni JH; Hu GX; Qian JC
    Food Chem Toxicol; 2023 Apr; 174():113669. PubMed ID: 36805545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC-MS/MS.
    Sillén H; Cook M; Davis P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2315-22. PubMed ID: 21727045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of resveratrol on the pharmacokinetics of ticagrelor in vivo and in vitro.
    Wang P; Hu XX; Li YH; Gao NY; Chen GQ; Chen JL
    Can J Physiol Pharmacol; 2021 Aug; 99(8):821-826. PubMed ID: 33400617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.
    Gao N; Zhang X; Hu X; Kong Q; Cai J; Hu G; Qian J
    Front Pharmacol; 2022; 13():794931. PubMed ID: 35359868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry.
    Sillén H; Cook M; Davis P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2299-306. PubMed ID: 20688583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of resveratrol on the pharmacokinetic of ibrutinib by UPLC-MS/MS.
    Wen J; Bao SS; Zhang BW; Liu TH; Ou-Yang QG; Cai JP; Zhou HY
    Drug Dev Ind Pharm; 2019 Jan; 45(1):27-31. PubMed ID: 30156133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS.
    Lin QM; Pang NH; Li YH; Huang HL; Zhang XD; Hu GX; Wang ZS
    Chem Biol Interact; 2019 Sep; 310():108744. PubMed ID: 31299239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
    Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
    Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes.
    Li Y; Wang E; Patten CJ; Chen L; Yang CS
    Drug Metab Dispos; 1994; 22(4):566-71. PubMed ID: 7956731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.